Medicine
Gabapentin 250 mg/5 mL oral solution
Gabapentin 250 mg/5 mL oral solution is a generic prescription medicine for oral use, made by 13 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store Gabapentin Oral Solution refrigerated, 2°C to 8°C (36°F to 46°F).
Key facts
- Active ingredient (INN)
- Gabapentin
- Brand
- Sold under the generic name
- Strength
- 250 mg/5 mL
- Dosage form
- Oral solution
- Route
- Oral
- Packs
- 1 bottle, 470 mL, 4 trays and 22 more
- Manufacturers
- Camber PharmaceuticalsIndiaAcella PharmaceuticalsAtlantic BiologicalsKesin PharmaPAI PharmaAmneal PharmaceuticalsAdvagen PharmaAjenat PharmaceuticalsAmerican Health PackagingBioComp Pharma
- Origin register
- US FDA, United States
- Storage
- Store Gabapentin Oral Solution refrigerated, 2°C to 8°C (36°F to 46°F).
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N02BF01 Gabapentin
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 30 September 2011
- Identifiers
- RxCUI 283523DailyMed set ID 63a5fc6d-ca57-4726-b70d-805ac023d959, 5969f1a8-d6d5-4967-add5-4e2492354d7b, 3f2ba3d6-6086-eaf2-e063-6294a90a7642 +11NDC 86211-112, 17856-0600, 81033-123 +13Application ANDA091286, ANDA076403, ANDA211330 +4
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 bottle in 1 carton / 470 mL in 1 bottle | 31722-069-47 | Camber PharmaceuticalsIndia | 17 January 2024 |
| 470 mL in 1 bottle, plastic | 0121-1067-16 | PAI Pharma | 12 June 2025 |
| 4 tray in 1 case / 10 cup, unit-dose in 1 tray / 6 mL in 1 cup, unit-dose | 0121-2134-40 | PAI Pharma | 12 June 2025 |
| 4 tray in 1 case / 10 cup, unit-dose in 1 tray / 5 mL in 1 cup, unit-dose | 0121-4067-40 | PAI Pharma | 12 June 2025 |
| 5 mL in 1 cup, unit-dose | 42192-608-05 | Acella Pharmaceuticals | 16 August 2019 |
| 6 mL in 1 cup, unit-dose | 42192-608-06 | Acella Pharmaceuticals | 16 August 2019 |
| 470 mL in 1 bottle | 42192-608-16 | Acella Pharmaceuticals | 1 October 2012 |
| 40 cup, unit-dose in 1 box / 6 mL in 1 cup, unit-dose | 42192-608-40 | Acella Pharmaceuticals | 16 August 2019 |
| 40 cup, unit-dose in 1 box / 5 mL in 1 cup, unit-dose | 42192-608-45 | Acella Pharmaceuticals | 5 May 2021 |
| 470 mL in 1 bottle | 72888-104-25 | Advagen Pharma | 12 June 2023 |
| 473 mL in 1 bottle | 82983-423-47 | Ajenat Pharmaceuticals | 6 August 2025 |
| 50 cup, unit-dose in 1 carton / 5 mL in 1 cup, unit-dose | 65162-698-54 | Amneal Pharmaceuticals | 30 September 2011 |
| 473 mL in 1 bottle | 65162-698-90 | Amneal Pharmaceuticals | 30 September 2011 |
| 470 mL in 1 bottle | 44523-120-16 | BioComp Pharma | 30 November 2023 |
| 473 mL in 1 bottle | 86211-112-01 | Jvet Pharmaceuticals | 15 December 2025 |
| 473 mL in 1 bottle | 81033-123-16 | Kesin Pharma | 1 September 2025 |
| 40 cup, unit-dose in 1 carton / 5 mL in 1 cup, unit-dose | 81033-123-44 | Kesin Pharma | 1 September 2025 |
| 40 cup, unit-dose in 1 carton / 6 mL in 1 cup, unit-dose | 81033-124-44 | Kesin Pharma | 1 September 2025 |
| 4 tray in 1 case / 10 cup, unit-dose in 1 tray / 6 mL in 1 cup, unit-dose | 60687-919-87 | American Health Packaging | 2 March 2026 |
| 72 cup, unit-dose in 1 box / 5 mL in 1 cup, unit-dose | 17856-0600-1 | Atlantic Biologicals | 7 May 2024 |
| 72 cup, unit-dose in 1 box / 6 mL in 1 cup, unit-dose | 17856-0600-2 | Atlantic Biologicals | 7 May 2024 |
| 5 box, unit-dose in 1 syringe / 120 syringe in 1 box, unit-dose / 2 mL in 1 syringe | 17856-0600-7 | Atlantic Biologicals | 7 May 2024 |
| 60 syringe in 1 box, unit-dose / 2 mL in 1 syringe | 17856-0600-8 | Atlantic Biologicals | 5 February 2025 |
| 470 mL in 1 bottle | 72162-1318-4 | Bryant Ranch Prepack | 1 November 2024 |
| 10 cup in 1 box / 10 mL in 1 cup | 70518-4445-0 | Remedyrepack | 16 August 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 30 December 1993 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Gabapentin 250 mg/5 mL oral solution.
Other strengths and forms of Gabapentin
Clinical summary
Gabapentin is an anti-epileptic agent indicated for management of postherpetic neuralgia in adults, among other approved uses. It is available as capsules, tablets and oral solution. MedsAcross supplies Gabapentin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about GabapentinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Neurontin prescribing information (Viatris Specialty) · U.S. National Library of Medicine, DailyMed
Need Gabapentin 250 mg/5 mL oral solution for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.